Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus

被引:63
作者
Koehl, JL
Muthaiyan, A
Jayaswal, RK
Ehlert, K
Labischinski, H
Wilkinson, BJ [1 ]
机构
[1] Illinois State Univ, Dept Biol Sci, Microbiol Grp, Normal, IL 61790 USA
[2] Bayer HealthCare, Pharma Res Ctr, Wuppertal, Germany
关键词
D O I
10.1128/AAC.48.10.3749-3757.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The cell wall composition and autolytic properties of passage-selected glycopeptide-intermediate Staphylococcus aureus (GISA) isolates and their parent strains were studied in order to investigate the mechanism of decreased vancomycin susceptibility. GISA had relatively modest changes in peptidoglycan composition involving peptidoglycan interpeptide bridges and somewhat decreased cross-linking compared to that of parent strains. The cell wall phosphorus content of GISA strains was lower than that of susceptible parent strains, indicating somewhat lower wall teichoic acid levels in the GISA strains. Similar to whole cells, isolated crude cell walls retaining autolytic activity of GISA had drastically reduced autolytic activity compared to that of parent strains, and this arose early in the development of the GISA phenotype. This was due to an alteration in the autolytic enzymes of GISA as revealed by normal susceptibility of GISA-purified cell walls to parental strain autolysin extract and lower activity and altered peptidoglycan hydrolase activity profiles in GISA autolysin extracts compared to those of parent strains. Northern blot analysis indicated that expression of ad, the major autolysin gene, was significantly downregulated in a GISA strain compared to that of its parent strain. In contrast to whole cells, which showed decreased lysostaphin susceptibility, purified cell walls of GISA showed increased susceptibility to lysostaphin. We suggest that in our GISA strains, decreased autolytic activity is involved in the tolerance of vancomycin and the activities of endogenous autolysins are important in conferring sensitivity to lysostaphin on whole cells.
引用
收藏
页码:3749 / 3757
页数:9
相关论文
共 54 条
[1]   Preliminary analysis of the genetic basis for vancomycin resistance in Staphylococcus aureus strain Mu50 [J].
Avison, MB ;
Bennett, PM ;
Howe, RA ;
Walsh, TR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (02) :255-260
[2]   Are the molecular strategies that control apoptosis conserved in bacteria? [J].
Bayles, KW .
TRENDS IN MICROBIOLOGY, 2003, 11 (07) :306-311
[3]  
Boyle-Vavra S, 2003, ANTIMICROB AGENTS CH, V47, P2036, DOI 10.1128/AAC.47.6.2036-2039.2003
[4]   Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate [J].
Boyle-Vavra, S ;
Carey, RB ;
Daum, RS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (05) :617-625
[5]   A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates [J].
Boyle-Vavra, S ;
Labischinski, H ;
Ebert, CC ;
Ehlert, K ;
Daum, RS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :280-287
[6]   The Staphylococcus aureus scdA gene: a novel locus that affects cell division and morphogenesis [J].
Brunskill, EW ;
deJonge, BLM ;
Bayles, KW .
MICROBIOLOGY-UK, 1997, 143 :2877-2882
[8]   Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus [J].
Climo, MW ;
Ehlert, K ;
Archer, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (05) :1431-1437
[9]   Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus [J].
Cui, L ;
Ma, XX ;
Sato, K ;
Okuma, K ;
Tenover, FC ;
Mamizuka, EM ;
Gemmell, CG ;
Kim, MN ;
Ploy, MC ;
El Solh, N ;
Ferraz, V ;
Hiramatsu, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :5-14
[10]   Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50 [J].
Cui, LZ ;
Murakami, H ;
Kuwahara-Arai, K ;
Hanaki, H ;
Hiramatsu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2276-2285